PROVIGIL Drug Patent Profile
✉ Email this page to a colleague
When do Provigil patents expire, and what generic alternatives are available?
Provigil is a drug marketed by Cephalon and is included in one NDA. There is one patent protecting this drug.
This drug has sixty-two patent family members in twenty-eight countries.
The generic ingredient in PROVIGIL is modafinil. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the modafinil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Provigil
A generic version of PROVIGIL was approved as modafinil by ORBION PHARMS on September 26th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROVIGIL?
- What are the global sales for PROVIGIL?
- What is Average Wholesale Price for PROVIGIL?
Summary for PROVIGIL
International Patents: | 62 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 71 |
Patent Applications: | 4,793 |
Drug Prices: | Drug price information for PROVIGIL |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PROVIGIL |
What excipients (inactive ingredients) are in PROVIGIL? | PROVIGIL excipients list |
DailyMed Link: | PROVIGIL at DailyMed |
Recent Clinical Trials for PROVIGIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kuwait University | Early Phase 1 |
The Ottawa Hospital | Phase 3 |
Bruyere Research Institute | Phase 3 |
Pharmacology for PROVIGIL
Drug Class | Sympathomimetic-like Agent |
Physiological Effect | Central Nervous System Stimulation Increased Sympathetic Activity |
US Patents and Regulatory Information for PROVIGIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-002 | Dec 24, 1998 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROVIGIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-002 | Dec 24, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROVIGIL
See the table below for patents covering PROVIGIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | PI0210085 | composição farmacêutica sólida contendo modafinila e processo para preparar uma composição farmacêutica sólida contendo modafinila | ⤷ Sign Up |
Malaysia | 129376 | NOVEL PHARMACEUTICAL FORMULATIONS OF MODAFINIL | ⤷ Sign Up |
Hong Kong | 1078265 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |